Clinical Trials Logo

Filter by:
NCT ID: NCT05515549 Not yet recruiting - Clinical trials for Venous Thromboembolic Disease

Value of D-dimer Combined With Other Thrombus Molecular Markers in Risk Assessment of VTE in Hospitalized Patients

Start date: January 2023
Phase:
Study type: Observational

The occurrence of VTE in hospital is an important cause of unexpected death of inpatients, and has become a serious problem faced by hospital managers and clinical medical staff.Under the target of "Improving the Standard Prevention Rate of Venous Thromboembolism" proposed in the "National Medical Quality and Safety Improvement Goal in 2022", it is urgent to establish a highly sensitive VTE risk assessment and monitoring system.At present, VTE risk assessment scale is used for risk screening and monitoring in combination with D-dimer in clinical practice, but D-dimer has low specificity and poor sensitivity, which makes it impossible to accurately assess the risk of venous thrombosis.Therefore, it is very important to explore highly specific molecular markers of thrombosis for VTE risk assessment.This project will analyze the value of single or combined detection of different thrombus molecular markers in VTE risk assessment, establish the best VTE risk assessment scheme, improve the standardized prevention of VTE, realize the early intervention of VTE, truly achieve early detection, early prevention and early treatment, and effectively reduce the occurrence of VTE.

NCT ID: NCT05515185 Not yet recruiting - Clinical trials for Advanced Solid Tumor

B7-H3 Targeting CAR-T Cells Therapy for B7-H3 Positive Solid Tumors

Start date: September 9, 2022
Phase: Early Phase 1
Study type: Interventional

This is a clinical study to evaluate the safety and efficacy of CAR-T cells in the treatment of patients with advanced solid tumors in China.

NCT ID: NCT05515133 Not yet recruiting - Glioblastoma Clinical Trials

Correlation Between Psychological Stress and Disease Progression in Newly Diagnosed Glioblastoma Patients

Start date: December 15, 2022
Phase:
Study type: Observational

It is a single-center, prospective, observational,non-randomized study of newly diagnosed glioblastoma patients conducted in a tertiary hospital. The investigators examine the psychological stress, immune biomarker changes, quality of life, and disease progression of patients with glioblastoma at five-time points. The study had two cohorts, a high-stress cohort and a low-stress cohort, which are grouped after initial recruitment. Both groups undergo total resection of tumors and received 3 months of standardized treatment with radiotherapy and chemotherapy. Neither participants nor doctors but the researcher can choose which group participants are in. No one knows if one study group is better or worse than the other.

NCT ID: NCT05514210 Not yet recruiting - Clinical trials for Coronary Artery Disease

Feasibility and Effectiveness of a Real-time Heart Team Approach in Complex CAD

Start date: June 20, 2023
Phase: N/A
Study type: Interventional

This study is aimed to evaluate the clinical outcomes, efficiency and feasibility of the real-time heart team approach and the conventional heart team approach.

NCT ID: NCT05513664 Not yet recruiting - Clinical trials for Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Real-World Effectiveness of Osimertinib for Patients With Non-Small Cell Lung Cancer

Start date: September 2022
Phase:
Study type: Observational

This study is a retrospective real-world study to evaluate the efficacy of Osimertinib for patients with advanced or metastatic EGFR 20exon insertion mutation (20ins) Non-Small Cell Lung Cancer.

NCT ID: NCT05512325 Not yet recruiting - Genetic Change Clinical Trials

Study on Gene Evolution in Glioma Under Stress Therapy

Start date: December 17, 2022
Phase:
Study type: Observational [Patient Registry]

Little is known about the evolution of genetic and epigenetic changes that occur in the progression of glioma. We inferred the evolution trajectories of matched pairs of primary tumors and progression tumor in situ fluid (TISF) based on deep whole-genome-sequencing data (ctDNA). A monocentric, Gene grouping controlled trial design was used to select patients. and to compare gene evolution of different subtypes of glioma under therapy. To predict the molecular reaction of bevacizumab treatment, clarify the mechanism of drug resistance of bevacizumab treatment.

NCT ID: NCT05512286 Not yet recruiting - Breast Cancer Clinical Trials

Patient-Reported Outcome and Safety Between Preoperative and Postmastectomy Radiotherapy in DIEP Flap Reconstruction

CAPPELLA
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

This study is the first prospective randomized study assessing the patient-reported outcomes and safety outcomes between preoperative and postmastectomy radiotherapy in locally advanced breast cancer patients with immediate reconstruction of deep inferior epigastric perforator(DIEP) flap. Radiotherapy before mastectomy and autologous free-flap breast reconstruction can avoid adverse radiation effects on healthy donor tissues and delays to adjuvant radiotherapy. We aimed to explore the feasibility of preoperative radiotherapy followed by DIEP flap reconstruction in patients with breast cancer requiring mastectomy.

NCT ID: NCT05511662 Not yet recruiting - Atrial Fibrillation Clinical Trials

Patient-reported Outcome Follow-up Based on the Northern Shanghai Community Chronic Disease Management System

Start date: September 1, 2022
Phase:
Study type: Observational

Influence of patient-reported outcome follow-up based on the northern Shanghai community chronic disease management system on the follow-up compliance and satisfaction of patients with atrial fibrillation after cryoablation.

NCT ID: NCT05510986 Not yet recruiting - Effect of Drug Clinical Trials

The Effect of Oxycodone Hydrochloride on CRBD After TURBT Under General Anesthesia

Start date: October 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effect of Oxycodone Hydrochloride on catheter-related bladder discomfort in patients undergoing transurethral resection of bladder tumor after general anesthesia.

NCT ID: NCT05510830 Not yet recruiting - Cervical Cancer Clinical Trials

Diagnostic Cervical Conization for Persistent Infection or Integration of HPV

Start date: October 2022
Phase: N/A
Study type: Interventional

For the patients with cervical persistent infection or integration of HPV, we has designed a program to perform cervical conization for certain patients to earlier and better diagnose and cure the diseases of HPV infection and related cervical intraepithelial neoplasia/cancer.